Stock Screener
US stocks rated by the Lician Quant model: a 1–5 rating and A+ to F grades for valuation, growth, profitability, momentum and EPS revisions, each against the stock’s sector. Filter, sort by any factor and share the URL.
39 stocks · Strong Buy or Buy · Healthcare · Short ≥ 10% of float
| Stock | Quant ratingRating | ValuationVal | GrowthGrow | ProfitabilityProf | MomentumMom | EPS revisionsRev | Market capMkt cap | P/EP/E | Revenue growthRev YoY | Div. yieldYield | Short % floatShort | Next earningsEarnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1QTTBQ32 Bio Inc | 5.00Strong Buy | A+ | — | A+ | B | A | $206M | 6.1 | — | — | 57.9% | Nov 12 |
| 2AVAHAveanna Healthcare Holdings Inc | 4.99Strong Buy | A | A- | B+ | A | A+ | $2.9B | 10.6 | +19.5% | — | 10.2% | Nov 12 |
| 3CDNACareDx Inc | 4.98Strong Buy | C+ | B+ | A+ | A+ | A+ | $3.6B | 32.2 | +34.4% | — | 13.6% | — |
| 4HALOHalozyme Therapeutics Inc | 4.97Strong Buy | C | B+ | A+ | A+ | A+ | $14.7B | 35.4 | +41.2% | — | 11.2% | Nov 5 |
| 5BTSGBrightSpring Health Services, Inc. Common Stock | 4.96Strong Buy | A- | A- | B- | A | — | $11.6B | 28.4 | +22.9% | — | 12.0% | — |
| 6ARQTArcutis Biotherapeutics Inc | 4.92Strong Buy | C+ | A+ | A- | A- | B+ | $3.9B | 137.4 | +76.1% | — | 23.9% | Nov 4 |
| 7INVAInnoviva Inc | 4.89Strong Buy | A+ | B+ | A+ | C- | A- | $1.5B | 4.3 | +18.8% | — | 10.5% | Nov 4 |
| 8OMEROmeros Corporation | 4.86Strong Buy | C | — | — | A- | A+ | $1.2B | 9.6 | — | — | 20.4% | Nov 12 |
| 9MGTXMeiraGTx Holdings PLC | 4.82Strong Buy | A | A+ | A+ | D | B- | $897M | 11.4 | +948.3% | — | 17.6% | Nov 12 |
| 10RIGLRigel Pharmaceuticals Inc | 4.82Strong Buy | A+ | B+ | A+ | A | D- | $895M | 2.8 | +3.3% | — | 18.3% | Nov 5 |
| 11PDEXPro-Dex Inc | 4.79Strong Buy | A | A- | B+ | C+ | A- | $184M | 13.4 | +16.5% | — | 13.0% | — |
| 12GRDNGuardian Pharmacy Services, Inc. | 4.73Strong Buy | A+ | — | B | C+ | B | $359M | 5.4 | +10.3% | — | 26.1% | Nov 5 |
| 13EXELExelixis Inc | 4.69Strong Buy | C+ | B | A+ | A+ | C- | $17.5B | 19.7 | +9.1% | — | 13.4% | — |
| 14ANIPANI Pharmaceuticals Inc | 4.67Strong Buy | A+ | A | A | D | C+ | $1.6B | 14.8 | +30.9% | — | 22.7% | Nov 5 |
| 15MDTMedtronic PLC | 4.64Strong Buy | A | C+ | A- | B+ | B- | $127B | 24.2 | +9.8% | 0.00% | 10.8% | Nov 17 |
| 16GRALGRAIL, LLC | 4.48Buy | D+ | A- | D+ | A | A+ | $5.6B | NM | +23.1% | — | 24.4% | Nov 4 |
| 17NEONeoGenomics Inc | 4.40Buy | B- | B- | C+ | B+ | A | $2.1B | NM | +11.2% | — | 11.8% | — |
| 18INSPInspire Medical Systems Inc | 4.33Buy | A | B+ | A | C- | C- | $2.1B | 15.2 | +4.3% | — | 16.7% | — |
| 19SGRYSurgery Partners Inc | 4.30Buy | A- | D+ | B | A- | B- | $3.0B | NM | +4.0% | — | 26.4% | Nov 9 |
| 20LQDALiquidia Technologies Inc | 4.15Buy | B | A+ | A+ | C | F | $3.8B | 27.4 | +2,234% | — | 26.1% | — |
| 21CRMDCorMedix Inc | 4.14Buy | A+ | A+ | A+ | F | D- | $579M | 3.1 | — | — | 22.0% | Nov 11 |
| 22ATRCAtriCure Inc | 4.12Buy | C+ | B | B | A+ | D | $3.0B | 284.2 | +13.9% | — | 10.1% | — |
| 23VCELVericel Corp Ord | 4.09Buy | B- | A- | B+ | C | C | $2.1B | 86.7 | +23.0% | — | 10.5% | Nov 5 |
| 24DVADaVita HealthCare Partners Inc | 4.07Buy | A- | C+ | A- | C+ | C | $11.8B | 12.8 | +6.4% | — | 12.9% | — |
| 25BCYCBicycle Therapeutics Ltd | 4.04Buy | B+ | A+ | D+ | D | A- | $257M | NM | +194.7% | — | 183.3% | — |
Showing 25 of 39
Source: Lician Quant Grades (SEC EDGAR statements, EODHD prices and estimates); short interest: FINRA; earnings dates: earnings calendar; dividend yield: EODHD fundamentals · Quant run Nov 4, 2026
Grades rank each stock against its sector peers; they are not investment advice. How the rating and grades work · Short interest · Earnings calendar